Side Effects of Onglyza, Similar Diabetes Drugs More Likely To Cause Kidney Damage Than SGLT2 Inhibitors: Study
A new study finds that diabetes drugs like Invokana are less likely to cause kidney problems than drugs like Onglyza and Januvia.
A new study finds that diabetes drugs like Invokana are less likely to cause kidney problems than drugs like Onglyza and Januvia.
A new study questions the decision of the FDA to place acute kidney injury warnings on Invokana and similar diabetes drugs.
An Onglyza lawsuit claims the manufacturers hid the drug's risk of heart failure from the medical community.
Onglyza litigation will be conducted in two phases, with the first dedicated to determining if plaintiffs can make a solid general causation case.
Defendants want plaintiffs involved in Onglyza litigation to show they can prove a link between the diabetes drug and heart failure before the litigation proceeds.
An Onglyza lawsuit claims that the side effects of the diabetes drug led to heart failure and death for a Nevada woman's husband.
A federal judge has appointed a number of plaintiffs' attorneys to leadership positions in Onglyza heart failure litigation.
An Onglyza lawsuit claims that the diabetes drug resulted in heart damage and heart failure for a Kentucky woman.
The side effects of the diabetes drugs Onglyza and Kombiglyze resulted in heart failure and cardiovascular injury for a Texas man, according to a recently filed lawsuit.
An Onglyza lawsuit indicates the manufacturers misled the public and medical community about the safety of the diabetes drug, resulting in the plaintiff's congestive heart failure.